Home » Posts tagged with » ArrowMark Partners
US medical device company Adagio Medical raises $42.5m in Series E

US medical device company Adagio Medical raises $42.5m in Series E

Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]

Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates

Lyra Therapeutics has raised $30 million in a Series C financing round to advance its lead product candidates for the treatment of chronic rhinosinusitis (CRS). Known as an inflammatory disease of the paranasal sinuses, chronic rhinosinusitis is said to affect around 14 million people in the US. The lead product candidates of the US-based clinical-stage […]

Continue reading …
ORIC Pharmaceuticals raises $55m to advance cancer resistance drugs

US oncology company ORIC Pharmaceuticals has raised $55 million through a Series D financing round to advance its pipeline of cancer resistance drugs, as per the latest pharma industry news. The financing brings the total capital raised by the San Fransisco-based ORIC Pharmaceuticals to more than $175 million. Leading the Series D financing round of the […]

Continue reading …
Gene therapy company 4D Molecular Therapeutics raises $90m in new funding

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $90 million through a Series B financing round. Viking Global Investors led the new funding round in the gene therapy company with ArrowMark Partners, Janus Henderson Investors, The Biotechnology Value Fund, […]

Continue reading …